Wilson Sonsini-Led Biotech Firm Rallies After $124M IPO
Blood cancer therapy developer Arcellx Inc. saw shares rally on Friday after pricing a $124 million initial public offering at the bottom of its range, guided by Wilson Sonsini Goodrich &...To view the full article, register now.
Already a subscriber? Click here to view full article